|
2021
|
Invention
|
Solanesol vaccine adjuvants and methods of preparing same. This disclosure describes the use of s... |
|
|
Invention
|
Live-attenuated rna hybrid vaccine technology. This disclosure provides ribonucleic acid (RNA) po... |
|
|
Invention
|
Genetically-adjuvanted rna vaccines. The present application discloses a genetically-adjuvanted R... |
|
|
Invention
|
Co-lyophilized rna and nanostructured lipid carrier. This disclosure provides thermostable, lyoph... |
|
|
Invention
|
Purified saponins and chromatographic process for purification of same. Substantially pure saponi... |
|
2020
|
Invention
|
Rig-i agonist and adjuvant formulation for tumor treatment. Cancer immunotherapies effective for ... |
|
|
Invention
|
Methods and compositions of astrovirus replicons. The present invention provides recombinant repl... |
|
|
Invention
|
Composition and method for spray drying an adjuvant vaccine emulsion. The invention provides for ... |
|
|
Invention
|
Vaccine composition containing synthetic adjuvant.
Compositions and methods, including vaccines ... |
|
|
Invention
|
Methods of using a vaccine composition containing synthetic adjuvant.
Compositions and methods, ... |
|
2018
|
Invention
|
Liposomal formulations comprising saponin and methods of use.
Provided herein are liposomal form... |
|
|
Invention
|
Liposomal formulations comprising saponin and methods of use. Provided herein are liposomal formu... |
|
|
Invention
|
Nanostructured lipid carriers and stable emulsions and uses thereof. Provided herein are nanostru... |
|
|
Invention
|
Cpzen compositions and uses.
Capreomycin sulfate and CPZEN-45, which act in non-identical manner... |
|
|
Invention
|
Cpzen compositions and uses. Capreomycin sulfate and CPZEN45, which act in non-identical manners ... |
|
2017
|
Invention
|
Mycobacterium tuberculosis polypeptides and fusions thereof. tuberculosis infections. |
|
|
Invention
|
Synthetic glucopyranosyl lipid adjuvants. Compounds, particularly, glucopyranosyl lipid adjuvant ... |
|
|
Invention
|
Vaccines comprising mycobacterium leprae polypeptides for the prevention, treatment, and diagnosi... |
|
|
Invention
|
West nile virus vaccine and method of use thereof. A West Nile virus (WNV) vaccine for human use ... |
|
|
Invention
|
Nanoalum particles containing a sizing agent. Provided herein are nanoalum particles comprising a... |
|
|
Invention
|
Compositions and methods for treating secondary tuberculosis and nontuberculosis mycobacterium in... |
|
|
Invention
|
Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium inf... |
|
|
Invention
|
Pegylated liposomes and methods of use. Provided herein are PEGylated liposomes, and methods of m... |
|
|
Invention
|
Formulation containing tlr agonist and methods of use. Stable aqueous formulations of adjuvant co... |
|
2014
|
Invention
|
Single vial vaccine formulations. The invention provides for thermostable lyophilized formulation... |
|
|
Invention
|
Compounds and methods for diagnosis and treatment of leishmaniasis.
Compounds and methods are pr... |
|
|
Invention
|
Compositions and methods for reducing or preventing metastasis. Compositions comprising glucopyra... |
|
|
Invention
|
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis.
Co... |
|
|
Invention
|
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis. Com... |
|
2013
|
Invention
|
Compositions and methods for treating an active mycobacterium tuberculosis infection.
The presen... |
|
|
Invention
|
Compositions and methods for treating an active mycobacterium tuberculosis infection. The present... |
|
|
Invention
|
Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis. Leishmania ant... |
|
|
Invention
|
Mycobacterium tuberculosis polypeptides and fusions thereof. Mycobacterium sp. antigens, and poly... |
|
|
Invention
|
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same. Formulatio... |
|
2011
|
Invention
|
Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) pol... |
|
|
Invention
|
Vaccines against toxoplasma gondii. Vaccines are disclosed against parasites. The vaccines includ... |
|
|
Invention
|
Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity.
The pre... |
|
|
Invention
|
Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity. The pres... |
|
|
Invention
|
Anti-xdr-tb drug, anti-mdr-tb drug, and combination anti-tuberculosis drug. A method for treating... |
|
2010
|
Invention
|
Compounds and methods for diagnosis and treatment of leishmaniasis. Leishmania antigens, or a var... |
